Literature DB >> 14597599

Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.

Bernhard Erdlenbruch1, Mehrnaz Alipour, Gert Fricker, David S Miller, Wilfried Kugler, Hansjörg Eibl, Max Lakomek.   

Abstract

1. The blood-brain barrier (BBB) represents the major impediment to successful delivery of therapeutic agents to target tissue within the central nervous system. Intracarotid alkylglycerols have been shown to increase the transfer of chemotherapeutics across the BBB. 2. We investigated the spatial distribution of intracarotid fluorescein sodium and intravenous lissamine-rhodamine B200 (RB 200)-albumin in the brain of normal and C6 glioma-bearing rats after intracarotid co-administration of 1-O-pentylglycerol (200 mm). To elucidate the mechanisms involved in the alkylglycerol-mediated BBB opening, intraluminal accumulation of fluorescein isothiocyanate (FITC)-dextran 40,000 was studied in freshly isolated rat brain capillaries using confocal microscopy during incubation with different alkylglycerols. Furthermore, 1-O-pentylglycerol-induced increase in delivery of methotrexate (MTX) to the brain was evaluated in nude mice. 3. Microscopic evaluation showed a marked 1-O-pentylglycerol-induced extravasation of fluorescein and RB 200-albumin in the ipsilateral normal brain. In glioma-bearing rats, increased tissue fluorescence was found in both tumor tissue and brain surrounding tumor. Confocal microscopy revealed a time- and concentration-dependent accumulation of FITC-dextran 40,000 within the lumina of isolated rat brain capillaries during incubation with 1-O-pentylglycerol and 2-O-hexyldiglycerol, indicating enhanced paracellular transfer via tight junctions. Intracarotid co-administration of MTX and 1-O-pentylglycerol (200 mm) in nude mice resulted in a significant increase in MTX concentrations in the ipsilateral brain as compared to controls without 1-O-pentylglycerol (P<0.005). 4. In conclusion, 1-O-pentylglycerol increases delivery of small and large compounds to normal brain and brain tumors and this effect is mediated at least in part by enhanced permeability of tight junctions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597599      PMCID: PMC1574140          DOI: 10.1038/sj.bjp.0705554

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

1.  Xenobiotic transport across isolated brain microvessels studied by confocal microscopy.

Authors:  D S Miller; S N Nobmann; H Gutmann; M Toeroek; J Drewe; G Fricker
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

Review 2.  Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.

Authors:  R A Kroll; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-05       Impact factor: 4.654

3.  Indirect coupling of organic anion secretion to sodium in teleost (Paralichthys lethostigma) renal tubules.

Authors:  D S Miller; J B Pritchard
Journal:  Am J Physiol       Date:  1991-12

4.  Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors.

Authors:  K E Warren; M C Patel; A A Aikin; B Widemann; M Libucha; P C Adamson; R Neuwirth; D Benziger; T O'Toole; K Ford; N Patronas; R J Packer; F M Balis
Journal:  Cancer Chemother Pharmacol       Date:  2001-10       Impact factor: 3.333

5.  Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

Authors:  L D McAllister; N D Doolittle; P E Guastadisegni; D F Kraemer; C A Lacy; J R Crossen; E A Neuwelt
Journal:  Neurosurgery       Date:  2000-01       Impact factor: 4.654

6.  Body distribution of free, liposomal and nanoparticle-associated mitoxantrone in B16-melanoma-bearing mice.

Authors:  R Reszka; P Beck; I Fichtner; M Hentschel; J Richter; J Kreuter
Journal:  J Pharmacol Exp Ther       Date:  1997-01       Impact factor: 4.030

7.  The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.

Authors:  S A Dahlborg; A Petrillo; J R Crossen; S Roman-Goldstein; N D Doolittle; K H Fuller; E A Neuwelt
Journal:  Cancer J Sci Am       Date:  1998 Mar-Apr

8.  Brain drug delivery of small molecules using immunoliposomes.

Authors:  J Huwyler; D Wu; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 9.  Drug transfer across the blood-brain barrier and improvement of brain delivery.

Authors:  P Jolliet-Riant; J P Tillement
Journal:  Fundam Clin Pharmacol       Date:  1999       Impact factor: 2.748

10.  Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.

Authors:  R A Kroll; M A Pagel; L L Muldoon; S Roman-Goldstein; S A Fiamengo; E A Neuwelt
Journal:  Neurosurgery       Date:  1998-10       Impact factor: 4.654

View more
  29 in total

Review 1.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

2.  Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging.

Authors:  Robert M Koffie; Christian T Farrar; Laiq-Jan Saidi; Christopher M William; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

3.  Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice.

Authors:  Aaron L Olsen; John D Morrey; Donald F Smee; Robert W Sidwell
Journal:  Antiviral Res       Date:  2006-12-20       Impact factor: 5.970

Review 4.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

Review 5.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 6.  Getting into the brain: approaches to enhance brain drug delivery.

Authors:  Mayur M Patel; Bhoomika R Goyal; Shraddha V Bhadada; Jay S Bhatt; Avani F Amin
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

7.  Acute effects of short-chain alkylglycerols on blood-brain barrier properties of cultured brain endothelial cells.

Authors:  P Hülper; S Veszelka; F R Walter; H Wolburg; P Fallier-Becker; J Piontek; I E Blasig; M Lakomek; W Kugler; M A Deli
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 8.  An update on the therapeutic role of alkylglycerols.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Mar Drugs       Date:  2010-08-05       Impact factor: 5.118

9.  Monitoring proteins using in vivo near-infrared time-domain optical imaging after 2-O-hexyldiglycerol-mediated transfer to the brain.

Authors:  Petra Hülper; Christian Dullin; Wilfried Kugler; Max Lakomek; Bernhard Erdlenbruch
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

10.  Brain endothelial cell-cell junctions: how to "open" the blood brain barrier.

Authors:  Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.